High-Throughput Genomic Analysis in Waldenstrom's Macroglobulinemia

被引:19
作者
Poulain, Stephanie [2 ]
Braggio, Esteban [3 ]
Roumier, Christophe [1 ,4 ]
Aijjou, Rachid [2 ]
Broucqsault, Natacha [4 ]
Galiegue-Zouitina, Sylvie [4 ]
Manier, Salomon [1 ]
Soenen, Valerie [1 ,4 ]
Nibourel, Olivier [1 ,4 ]
Duthilleul, Patrick [2 ]
Fonseca, Rafael [3 ]
Leleu, Xavier [1 ,4 ]
机构
[1] CHRU, Serv Malad Sang, F-59037 Lille, France
[2] CH Valenciennes, UF Biol Mol, Valenciennes, France
[3] Mayo Clin, Scottsdale, AZ USA
[4] IRCL, Ctr Rech Inserm 837, Equipe 3, Lille, France
关键词
KAPPA-B PATHWAY; 6Q DELETION; MALIGNANCIES; MUTATIONS;
D O I
10.3816/CLML.2011.n.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Single-nucleotide polymorphism array (SNPa) and array-based comparative genomic hybridization (aCGH) are among the most sensitive genomic high-throughput screening techniques used in the exploration of genetic abnormalities in Waldenstrom's macroglobulinemia (WM). SNP and aCGH allow the identification of copy number abnormalities (CNA) at the kilobase level thus identifying cryptic genetic abnormalities unseen by lower-resolution approaches such as conventional cytogenetic or fluorescence in situ hybridization (FISH). CNA were identified in nearly 80% of cases by aCGH that delineated in addition minimal altered regions. At gene level, remarkable findings affecting genes involved in the regulation of the NF-kB signaling pathways were identified, such as biallelic inactivation of TNFAIP3 and TRAF3. SNPa also allowed characterization of copy neutral losses such as uniparental disomies (UPD), which is an important and frequent mechanism of gene alteration in cancer cells. Herein, we summarize the current knowledge of WM genomic basis using these high-throughput techniques.
引用
收藏
页码:106 / 108
页数:3
相关论文
共 18 条
  • [1] Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenstrom's Macroglobulinemia
    Braggio, Esteban
    Keats, Jonathan J.
    Leleu, Xavier
    Van Wier, Scott
    Jimenez-Zepeda, Victor H.
    Valdez, Riccardo
    Schop, Roelandt F. J.
    Price-Troska, Tammy
    Henderson, Kimberly
    Sacco, Antonio
    Azab, Feda
    Greipp, Philip
    Gertz, Morie
    Hayman, Suzanne
    Rajkumar, S. Vincent
    Carpten, John
    Chesi, Marta
    Barrett, Michael
    Stewart, A. Keith
    Dogan, Ahmet
    Bergsagel, Leif
    Ghobrial, Irene M.
    Fonseca, Rafael
    [J]. CANCER RESEARCH, 2009, 69 (08) : 3579 - 3588
  • [2] Analysis of 6q deletion in Waldenstrom macroglobulinemia
    Chang, Hong
    Qi, Xiaoying
    Xu, Wei
    Reader, Jocelyn C.
    Ning, Yi
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (03) : 244 - 247
  • [3] TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-κB pathway by TRAF-binding TNFRs
    Hauer, J
    Püschner, S
    Ramakrishnan, P
    Simon, U
    Bongers, M
    Federle, C
    Engelmann, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (08) : 2874 - 2879
  • [4] TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
    Honma, Keiichiro
    Tsuzuki, Shinobu
    Nakagawa, Masao
    Tagawa, Hiroyuki
    Nakamura, Shigeo
    Morishima, Yasuo
    Seto, Masao
    [J]. BLOOD, 2009, 114 (12) : 2467 - 2475
  • [5] Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma
    Keats, Jonathan J.
    Fonseca, Rafael
    Chesi, Marta
    Schop, Roelandt
    Baker, Angela
    Ching, Wee-Joo
    Van Wier, Scott
    Tiedemann, Rodger
    Shi, Chang-Xin
    Sebag, Michael
    Braggio, Esteban
    Henry, Travis
    Zhu, Yuan-Xiao
    Fogle, Homer
    Price-Troska, Tammy
    Ahmann, Gregory
    Mancini, Catherine
    Brents, Leslie A.
    Kumar, Shaji
    Greipp, Philip
    Dispenzieri, Angela
    Bryant, Barb
    Mulligan, George
    Bruhn, Laurakay
    Barrett, Michael
    Valdez, Riccardo
    Trent, Jeff
    Stewart, A. Keith
    Carpten, John
    Bergsagel, P. Leif
    [J]. CANCER CELL, 2007, 12 (02) : 131 - 144
  • [6] Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies
    Maciejewski, Jaroslaw P.
    Tiu, Ramon V.
    O'Keefe, Christine
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (05) : 479 - 488
  • [7] Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies
    O'Keefe, Christine
    McDevitt, Michael A.
    Maciejewski, Jaroslaw P.
    [J]. BLOOD, 2010, 115 (14) : 2731 - 2739
  • [8] 6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis
    Ocio, E. M.
    Schop, R. F. J.
    Gonzalez, B.
    Van Wier, S. A.
    Hernandez-Rivas, J. M.
    Gutierrez, N. C.
    Garcia-Sanz, R.
    Moro, M. J.
    Aguilera, C.
    Hernandez, J.
    Xu, R.
    Greipp, P. R.
    Dispenzieri, A.
    Jalal, S. M.
    Lacy, M. Q.
    Gonzalez-Paz, N.
    Gertz, M. A.
    San Miguel, J. F.
    Fonseca, R.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (01) : 80 - 86
  • [9] Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia
    Owen, RG
    Treon, SP
    Al-Katib, A
    Fonseca, R
    Greipp, PR
    McMaster, ML
    Morra, E
    Pangalis, GA
    Miguel, JFS
    Branagan, AR
    Dimopoulos, MA
    [J]. SEMINARS IN ONCOLOGY, 2003, 30 (02) : 110 - 115
  • [10] POULAIN S, 2010, BLOOD